Results 181 to 190 of about 1,553,975 (340)
"Closing the gap in the wrong direction" migration, health policy, and the exclusion of asylum seekers, refugees and undocumented migrants from healthcare access in South Africa. [PDF]
Walker R, Vearey J.
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Lymphedema Treatment Act: A Critical Step for Cancer Survivors, but Unresolved Equity Gaps Persist. [PDF]
Hassan AM, Chang EI, Hassanein AH.
europepmc +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
Can administrative data be used for a national register of hospitalised stroke patients? A New Zealand validation study. [PDF]
Corbin M +15 more
europepmc +1 more source
The Transformation of the Agricultural Administration in East Germany Before and After Unification [PDF]
With the collapse of the socialist regime in East Germany in late 1989 and the rising political call for unification in early 1990, a deep change of the institutional structure became necessary.
Wolz, Axel
core +1 more source
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang +8 more
wiley +1 more source
Patient administrative burden: a scoping review. [PDF]
Kyle MA, Feng KY, Wade CG, Yaver M.
europepmc +1 more source

